Tesaro (TSRO) News Today → [Urgent!] Generational Wealth Gameplan (From Crypto 101 Media) (Ad) Free TSRO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineKeval Desai's Net Worthbenzinga.com - February 22 at 2:15 PMTesaro (TSRO) Stock Slumps on Public Offering, Leerink Lifts Price Targetthestreet.com - September 14 at 3:56 PMAnalysts Holding As Pfizer Waits On Two Phase 3 Studies (TSRO)marketbeat.com - February 24 at 9:05 AMDr. Marc Siegel Explains Why Tesaro (TSRO) Cancer Drug Is a Big Dealthestreet.com - January 3 at 11:59 PMImmunotherapy Drugs Market Worth $475+ Billion, Globally, by 2028 at 14+% CAGR | The Insight Partners - PR Newswireprnewswire.com - October 18 at 2:48 AMAnaptysBio and GSK-partnered immuno-oncology agents JEMPERLI (dostarlimab-gxly) and cobolimab show positive progress in two separate non-small cell lung cancer trials - Yahoo Financefinance.yahoo.com - October 5 at 5:30 PMANAPTYSBIO, INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.commarketscreener.com - September 12 at 6:56 PMDay One Appoints Garry Nicholson as Chairman of the Board of Directors - Yahoo Financefinance.yahoo.com - September 12 at 6:56 PMGlaxoSmithKline : GSK to highlight the latest advances in cancer research from across its portfolio and pipeline at ESMO - Marketscreener.commarketscreener.com - September 1 at 2:35 AMNorth America oncology market value to cross USD 246 billion by 2028 - GlobeNewswireglobenewswire.com - August 9 at 3:39 PMGlobal TIM3 Inhibitors Drug Clinical Trials & Market Opportunities Report 2022: Market to Surpass $1 Billion by 2028, Driven by the First Drug Approval Expected to be Launched by 2024 - Yahoo Financefinance.yahoo.com - August 8 at 6:44 PMTIM3 Inhibitors Drug Clinical Trials Research Report 2022: Insight on Emerging TIM3 Inhibitors in Development As Monotherapy & Combination Therapy - PR Newswireprnewswire.com - August 6 at 12:11 AMTIM3 Inhibitors Drug Clinical Trials Research Report 2022: Insight on Emerging TIM3 Inhibitors in Development As Monotherapy & Combination Therapy - Yahoo Financefinance.yahoo.com - August 5 at 1:36 PMTIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insights Report 2022-2028 - ResearchAndMarkets.com - Business Wirebusinesswire.com - August 4 at 7:33 AMTIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insight 2028 - Yahoo Financefinance.yahoo.com - July 21 at 1:23 PMTIM3 Inhibitors Drug Clinical Trials & Market Opportunity Insight 2028 - GlobeNewswireglobenewswire.com - July 21 at 8:23 AMAnti TIM3 Inhibitors Drugs Antibody Clinical Trials Market Report 2028 - GlobeNewswireglobenewswire.com - July 20 at 11:06 AMMetastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Insights | DelveInsight - GlobeNewswireglobenewswire.com - July 11 at 3:37 PMMary Lynne Hedley Elected to Lilly Board of Directors - GuruFocus.comgurufocus.com - June 25 at 7:03 PMXilio Therapeutics (XLO) Announces Promotion of Martin Huber, MD, to President - StreetInsider.comstreetinsider.com - June 16 at 10:54 AMJanssen to Highlight Science, Innovation and Advances in Robust Oncology Portfolio and Pipeline Through More Than 60 Data Presentations at ASCO and EHA - PR Newswireprnewswire.com - May 31 at 10:37 AMMary Lynne Hedley Elected to Lilly Board of Directors - Yahoo Financefinance.yahoo.com - May 8 at 9:34 AMMary Lynne Hedley Elected to Lilly Board of Directors - StreetInsider.comstreetinsider.com - May 7 at 12:26 PMEli Lilly & Co. (LLY) Appoints Mary Lynne Hedley to its Board - StreetInsider.comstreetinsider.com - May 6 at 3:34 PMMary Lynne Hedley Elected to Lilly Board of Directors - PR Newswireprnewswire.com - May 6 at 3:34 PMJanssen Submits Marketing Authorisation Application to EMA Seeking Approval of Niraparib and Abiraterone Acetate Dual Action Tablet Plus Prednisone for the Treatment of Patients with HRR Gene-Mutated Metastatic Castration Resistant Prostate Cancer - Business Wirebusinesswire.com - April 28 at 2:23 PMGSK Agrees to Buy Sierra Oncology for $1.9 Billion in Cash - Bloombergbloomberg.com - April 13 at 4:16 AMDel. Justices Uphold Toss Of Suit Over Tesaro's $5.1B Sale - Law360law360.com - April 9 at 12:11 AMSofinnova Investments Announces the Addition of Dr. Chris Carpenter as Executive Partner - Business Wirebusinesswire.com - April 7 at 1:43 AM3 CEOs to Invest In - Nasdaqnasdaq.com - April 1 at 10:14 PMClovis Oncology: Forging A Fresh Perspective - Seeking Alphaseekingalpha.com - March 31 at 8:43 PMTesaro Sale Flaws Justify Case Remand, Del. Justices Told - Law360law360.com - March 30 at 5:10 PMGlobal Ovarian Cancer Drugs Market to 2031 - Featuring AstraZeneca, Roche and Tesaro Among Others - Yahoo Financefinance.yahoo.com - March 29 at 6:05 AM$3.25 Billion Worldwide Ovarian Cancer Drugs Industry 2022 - Identify Growth Segments for Investment - ResearchAndMarkets.com - Yahoo Financefinance.yahoo.com - March 28 at 7:08 AMOvarian Cancer Drugs Global Market Report 2022 - Yahoo Financefinance.yahoo.com - March 16 at 9:37 AMEPIZYME, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.commarketscreener.com - March 15 at 8:31 AMZai Lab: Shares Are Cheap, But Not Without Reason - Seeking Alphaseekingalpha.com - March 9 at 1:23 AMCatamaran Bio Announces Appointment of Michael DeRidder, PhD, as Senior Vice President, Corporate Strategy and New Product Planning - Business Wirebusinesswire.com - February 28 at 11:04 AMJanssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus Prednisone Significantly Improved Radiographic Progression-Free Survival as a First-Line Therapy in Patients with HRR Gene-Mutated Metastatic Castrati - PRNewswireprnewswire.com - February 14 at 5:34 PMJanssen Data at ASCO GU Demonstrate Longstanding Leadership in Prostate Cancer and Commitment to Advancing Potential New Therapeutic Options for Genitourinary Cancers - PRNewswireprnewswire.com - February 1 at 9:15 AMCancer Supportive Care Drugs Market to Reach $24.40 Bn, Globally, by 2030 at 2.2% CAGR: Allied Market Research - PRNewswireprnewswire.com - January 20 at 9:36 AMGlobal Pharma and Biotech Preclinical Stage Partnering Deals Directory 2021: Comprehensive Access to Deals and Contract Documents for Over 2,400 Deals - Yahoo Financefinance.yahoo.com - January 15 at 5:53 PMGlobal Pharma and Biotech Preclinical Stage Partnering Deals Directory 2021 - GlobeNewswireglobenewswire.com - January 14 at 5:13 PMWomen's Health Therapeutics Market Report Up to 2031: Visiongain Research Inc - GlobeNewswireglobenewswire.com - January 12 at 10:20 AMSleep Aids Market is expected to register a CAGR of 4.5% during the forecast period (2021-2031) - Benzing - Benzingabenzinga.com - December 3 at 8:14 AMPoly (ADP-Ribose) Polymerase Inhibitors Pipeline Research Report 2021: Comprehensive Insights About 20+ Companies and 20+ Pipeline Drugs - ResearchAndMarkets.com - Yahoo Financefinance.yahoo.com - December 2 at 3:16 PMPoly (ADP-Ribose) Polymerase Inhibitors Pipeline Research Report 2021: Comprehensive Insights About 20+ Companies and 20+ Pipeline Drugs - ResearchAndMarkets.com - Business Wirebusinesswire.com - December 1 at 1:23 PM4 Reasons Why You Should Add Glaxo (GSK) to Your Portfolio - Nasdaqnasdaq.com - November 16 at 12:48 PMACADIA PHARMACEUTICALS INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) - marketscreener.commarketscreener.com - November 5 at 6:18 PMNEA Welcomes Veteran Life Sciences Investor Michele Park as Partner on Its Healthcare Investing Team - StreetInsider.comstreetinsider.com - November 4 at 3:54 PM Get Tesaro News Delivered to You Automatically Sign up to receive the latest news and ratings for TSRO and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Perfect Storm” for Gold (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025. Click here now to download the free Precious Metals Buying Guide! TSRO Media Mentions By Week TSRO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TSRO News Sentiment▼0.000.39▲Average Medical News Sentiment TSRO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TSRO Articles This Week▼00▲TSRO Articles Average Week Get Tesaro News Delivered to You Automatically Sign up to receive the latest news and ratings for TSRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ALKS News Today MDGL News Today FOLD News Today IONS News Today GERN News Today DVAX News Today LGND News Today IRWD News Today MNKD News Today UTHR News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TSRO) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeBiden out June 13; Kamala won’t replace him?Paradigm PressTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsUrgent alert: open this for a huge profit potentialTimothy SykesYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tesaro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.